By now we're very familiar with the idea of the Too Big To Fail banks. This article about Pfizer shows us, however, that the problem is not limited to financial institutions.
My knee-jerk response is that if we want to truly protect the public, our entire regulatory structure has to completely shift focus to ensure that no companies ever get too big to fail. This could also have the nice side-effect of limiting the deleterious consequences of the Citizens United decision and eliminating many anti-trust concerns.
The two significant downsides I can see arethe creation of a more hostile environment for corporations and increased costs coming from the minimization of economies of scale.
But what other solutions are there?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment